Alan Long

750 total citations
11 papers, 547 citations indexed

About

Alan Long is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Alan Long has authored 11 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Alan Long's work include Immune Cell Function and Interaction (6 papers), IL-33, ST2, and ILC Pathways (4 papers) and Eosinophilic Esophagitis (2 papers). Alan Long is often cited by papers focused on Immune Cell Function and Interaction (6 papers), IL-33, ST2, and ILC Pathways (4 papers) and Eosinophilic Esophagitis (2 papers). Alan Long collaborates with scholars based in United States, China and Austria. Alan Long's co-authors include Jie Fan, Donye Dominguez, Siqi Chen, Lei Qin, Yi Zhang, Bin Zhang, Deyu Fang, Timothy M. Kuzel, Teh-wei Hu and Harvey J. Tucker and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Alan Long

11 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Long United States	10	286	128	123	120	118	11	547
Jiahong Xia China	10	85 0.3×	90 0.7×	113 0.9×	121 1.0×	82 0.7×	24	576
Gael B. Morrow United Kingdom	10	45 0.2×	50 0.4×	70 0.6×	53 0.4×	75 0.6×	17	509
Ashanty M. Melo Ireland	14	251 0.9×	56 0.4×	114 0.9×	105 0.9×	77 0.7×	30	509
Hiromasa Harada Japan	12	109 0.4×	50 0.4×	85 0.7×	64 0.5×	64 0.5×	20	438
Nekisa Zakeri United Kingdom	8	175 0.6×	92 0.7×	194 1.6×	81 0.7×	34 0.3×	18	457
Brian Susskind United States	15	304 1.1×	699 5.5×	110 0.9×	51 0.4×	90 0.8×	36	1.3k
Xiang He China	10	108 0.4×	93 0.7×	31 0.3×	57 0.5×	45 0.4×	19	390
Nancy G. Casanova United States	14	74 0.3×	27 0.2×	152 1.2×	45 0.4×	151 1.3×	28	516
Jonathan M. Keller United States	11	131 0.5×	26 0.2×	54 0.4×	117 1.0×	262 2.2×	22	610
Gregory W. Fink United States	11	101 0.4×	502 3.9×	116 0.9×	202 1.7×	67 0.6×	17	733

Countries citing papers authored by Alan Long

Since Specialization

Citations

This map shows the geographic impact of Alan Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Long more than expected).

Fields of papers citing papers by Alan Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Long. The network helps show where Alan Long may publish in the future.

Co-authorship network of co-authors of Alan Long

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Long. A scholar is included among the top collaborators of Alan Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Long. Alan Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Jiang, Hua, Alan Long, Maegan L. Capitano, et al.. (2021). Immunotherapy Targeting ST2/IL-33 Signaling in Myeloid Leukemia Stem Cells. Blood. 138(Supplement 1). 23–23. 1 indexed citations

2.

Lin, Tsung-Yi, Jeong A Park, Alan Long, Hong-Fen Guo, & Nai‐Kong V. Cheung. (2021). Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 9(9). e003114–e003114. 29 indexed citations

3.

Qin, Lei, Shuya Wang, Donye Dominguez, et al.. (2020). Development of Spherical Nucleic Acids for Prostate Cancer Immunotherapy. Frontiers in Immunology. 11. 1333–1333. 26 indexed citations

4.

Chen, Siqi, Jie Fan, Minghui Zhang, et al.. (2019). CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy. Nature Communications. 10(1). 150–150. 68 indexed citations

5.

Long, Alan, Donye Dominguez, Lei Qin, et al.. (2018). Type 2 Innate Lymphoid Cells Impede IL-33–Mediated Tumor Suppression. The Journal of Immunology. 201(11). 3456–3464. 57 indexed citations

6.

Zhang, Minghui, Donye Dominguez, Siqi Chen, et al.. (2017). WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability. Oncology Letters. 14(3). 3580–3586. 29 indexed citations

7.

Liotta, Eric M., Shyam Prabhakaran, Rajbeer Singh Sangha, et al.. (2017). Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage. Neurology. 89(8). 813–819. 44 indexed citations

8.

Dominguez, Donye, Cong Ye, Zhe Geng, et al.. (2016). Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer. The Journal of Immunology. 198(3). 1365–1375. 80 indexed citations

9.

Qin, Lei, Donye Dominguez, Siqi Chen, et al.. (2016). Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia. Oncotarget. 7(38). 61069–61080. 48 indexed citations

10.

Ye, Cong, Zhe Geng, Donye Dominguez, et al.. (2015). Targeting Ornithine Decarboxylase by α-Difluoromethylornithine Inhibits Tumor Growth by Impairing Myeloid-Derived Suppressor Cells. The Journal of Immunology. 196(2). 915–923. 57 indexed citations

11.

Long, Alan, et al.. (1995). Long-term survival after intensive care unit admission with sepsis. Critical Care Medicine. 23(6). 1040–1047. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact